India Way

Last week I was reading an article “India way” in Harvard business review, as per the book western companies the primary concern is to satisfy their share holder’s need which is very true and the same I feel this also applies to majority of the companies operating in the Indian service sector which are just focusing on short term revenues.

The best thing about the article is it has made me think about the core Indian company’s value proposition and how Indian companies have been different from the capitalist America. Professor Peter of Wharton, your article has helped me in evaluating the attributes required for starting and then sustaining a company as next generation entrepreneur :)

India Inc Update

Today after coming from office I was reading some paper on Harvard business review the India way, there they have mentioned about Dr Reddy's.....good article indeed and then was checking my regular updates in Gmail account and then one news caught my attention...Most of the generic Indian pharma's till date have been doing merger and acquisition in European and emerging markets such as Latin America mostly for research colloboration or buying the whole manufacturing unit as whole, but our own Dr Reddy's has established its own mPEG plant in Mexico thus now it will able to supply in cheaper rates raw materials to Northh America with huge profit margin, I feel this time Reddy's has taken a very right approach :)

Made in China...........

I have never been to Wal-Mart but what ever I have heard from my family members and friends is that in Wal-Mart stores what you get in cheap and affordable price is Made in China stuff. After some years time will come that our daily drugs will be made in china as Chinese government recently announced that it would like to be No 1 in terms of Biotechnology and Pharma research and development by year 2015 and today I read some IMS report stating that China is going to be third largest drug market by year 2011 and thus will contribute to around 48% to global pharmaceutical growth

last Week Updates.........................

Last week was a very busy week for me with lot of good work in terms of my close pharma industry interaction so was not able to give me time to my favorite past time intellectual driver.......Last week there were follwing updates........

1.Ratiopharm (With Market cap of more than  approximate $ 2-2.5 Billion) - Europe one of the largest generic maker is up for sale, three contendors are there for this deal, one is the largest pharma (Pfizer) and the other two are big names in the generic scenario are Teva (No1 -generic maker) and Activis (Iceland largest generic maker)

2. Merck and Sanofi aventis are going to expand big time in the animal health segment to attain the market leader position.

3. Abbott labs which last year had been expanding its opthalmology portfoilio

Pharma Updates.........

Last week was a very busy week for me with lot of good work in terms of my close pharma industry interaction so was not able to give me time to my favourite past time intellectual driver.......Last week there were following updates........

1.Ratiopharm (With Market cap of more than approximate $ 2-2.5 Billion) - Europe one of the largest generic maker is up for sale, three contenders are there for this deal, one is the largest pharma (Pfizer) and the other two are big names in the generic scenario are Teva (No1 -generic maker) and Activis (Iceland largest generic maker)

2. Merck and Sanofi aventis are going to expand big time in the animal health segment to attain the market leader position.

3. Abbott labs which last year had been expanding its ophthalmology portfolio by rapid M&A activity is this point of time expanding its oncology portfolio by acquiring California based Facet Lab for $722 million.
More updates coming this week :)

H1N1 India Inc Update

According to The Medguru news published on Feb 20, 2010. It reported that over the past six months 1, 330 people have been affected by H1N1 in India, according to the report Maharashtra has the highest death toll followed by Rajasthan then Karnataka and Delhi, total number of positives cases reported till date is 29, 452 individuals……..but now we have good news from Pune based Serum institute of India as report published in DNA India, Feb 14, 2010 , the company spokesperson stated that they had started vaccine development last year in the month of April and have completed phase I trial for H1N1 nasal drop, thus they are going to launch this nasal drop by this April, the company also stated that they are expecting to produce around 1.2 MIL dose of inject-able vaccines per month from this year Q2-Q3.

My review on Business Branding

Last year was good I did work on competitive intelligence, business analytics and my boss just asked me to work on one big sale's project, I was not sure about lead generation and all, first 3 days were the worst but after that there was no turning point. I love doing primary calling if required.....and in Business development it has become my primary bread earner. leave this apart Now adays I have seen one more trend coming up, companies with some innovation have started publishing in Harvard Business Review about how they have become innovative company, I don’t want to take the name of the companies but I have been observing this trend for quite long. there was one book I was reading last year Built k to last where the author's wrote about companies like Pfizer, Merck, Johnson and Johnson and so on, for Pfizer they mentioned the fact about its winning attitude but what ever was spoken about Merck and Johnson and Johnson I think things have changed a lot in these last 50 years. Making case studies like this will help in branding but we are still missing on something isn't it?

Merck KgA.................

Merck KgA was formed more than 100 years ago and from then it was known for its chemical manufacturing and then some 50 years back it started diversifying and after its investment in Biopharmaceuticals with Merck Serono in year 2006 for $11 Billion, today it has made an offer of $7.2 Billion for Millipore, earlier the speculation was  that thermo had made offer of around $5 Billion for millipore.......what I had assumed was companies like Lifetech , Qiagen, thermo type will be interested in this merger...with this acquisition now we have many more M&A to watch from  companies like Merck (Large Pharma) in these coming 2 years.